Author Affiliations: Department of Noncommunicable Disease Epidemiology, Cochrane Heart Group, London School of Hygiene and Tropical Medicine, London, England.
Evidence to support the use of statins for preventing recurrent cardiovascular disease (CVD) is strong, derived from individual patient data meta-analysis1 and from systematic reviews of randomized trials.2 This evidence underpins the use of statins in clinical guidelines internationally as an uncontroversial treatment for secondary prevention that is both cost-effective and safe.3- 5
Fiona Taylor, Shah Ebrahim. Statins Work Just as Well in Women as in MenComment on “Statin Therapy in the Prevention of Recurrent Cardiovascular Events”. Arch Intern Med. 2012;172(12):919–920. doi:10.1001/archinternmed.2012.2434